OCULAR THERAPEUTIX, INC Common Stock, Capital Shares Reserved for Future Issuance
OCULAR THERAPEUTIX, INC (OCUL) had Common Stock, Capital Shares Reserved for Future Issuance of 10.06 million shares as of 2025-12-31, per its 10-K filed 2026-02-05.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-02-05
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 10.06M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 9.26M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 24.93M shares.
- 2014-12-31: Common Stock, Capital Shares Reserved for Future Issuance 207.40K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 10.06M shares 10-K · filed 2026-02-05 |
| 2024-12-31 | 9.26M shares 10-K · filed 2025-03-03 |
| 2023-12-31 | 24.93M shares 10-K · filed 2024-03-11 |
| 2014-12-31 | 207.40K shares 10-K · filed 2015-03-20 |
| 2014-09-30 | 207.40K shares 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |